Radiopharm Theranostics (RADX) - Uzoq muddatli qarzning kapitalga nisbati
Radiopharm Theranostics (RADX) o'sishi radiofarmatsevtika ishlanmalari va FDA tasdiqlashlaridagi yutuqlar bilan bog'liq. Uzoq muddatli qarzning kapitalga nisbati moliyaviy barqarorlikni namoyish etadi va joriy daraja 0.00 ni tashkil etadi. Qat'iy yadroviy qoidalar va izotop yetkazib berish patentlari bozorga kirish uchun yuqori to'siqlarni yaratadi. Biznes yopiq biotexnologiya muhitida faoliyat yuritadi, bunda bemorlar to'liq ravishda ixtisoslashtirilgan tibbiyot markazlariga bog'langan.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_RADX_-_Radiopharm-Theranostics_-_Long-Term-Debt-to-Equity "radiopharmtheranostics.com (RADX): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi 06.12.2024dan 31.10.2026gacha | 👁️GURU.Markets👁️")
Radiopharm Theranostics kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati Radiopharm Theranostics|RADX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Radiopharm Theranostics Ltd|RADX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Radiopharm Theranostics Limited|RADX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Radiopharm Theranostics|Tezkor likvidlik koeffitsiyenti radiopharmtheranostics.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
Kompaniyaning umumiy tahlili:radiopharmtheranostics.com - RADX
Radiopharm Theranostics (RADX) kompaniyasining diversifikatsiyalashgan radiofarmatsevtika loyihalari uzoq muddatli rivojlanish uchun sezilarli investitsiyalarni talab qiladi. Uzoq muddatli qarzdorlikning kapitalga nisbati moliyalashtirish tuzilmasi ichidagi muddati bir yildan ortiq bo'lgan kreditlarning ulushini aks ettiradi. Ushbu metrika moliyaviy richagning darajasini o'lchash uchun uzoq muddatli majburiyatlarni kapitalning bozor qiymati bilan solishtiradi. Ushbu ko'rsatkichning oshishi qarz yukining ortishidan dalolat beradi, doimiy past qiymatlar esa yuqori to'lov qobiliyatini va aktivning ishonchliligini tasdiqlaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AURA (Aura Biosciences)|CADL (candeltx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ARAY (Accuray Inc.)|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACTU: Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR - Uzoq muddatli qarzning kapitalga nisbati|tuhurabio.com (HURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protara Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio WHWK|Uzoq muddatli qarzning o'z kapitaliga nisbati TScan Therapeutics (TCRX)|CSBR (championsoncology.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XBIT (XBiotech)|Uzoq muddatli qarzning kapitalga nisbati CEL-SCI Corp. CVM|OS Therapies Inc - Uzoq muddatli qarzning kapitalga nisbati|ARTV (Artiva Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ANL: Uzoq muddatli qarzning kapitalga nisbati|VERU - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Tempest Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Xilio XLO|Uzoq muddatli qarzning o'z kapitaliga nisbati Renovaro Inc. (RENB)|MURA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KAPA (Kairos Pharma)|Uzoq muddatli qarzning kapitalga koeffitsiyenti OKUR|CytoMed - Uzoq muddatli qarzning kapitalga nisbati|CRIS - Uzoq muddatli qarzning kapitalga nisbati|apollomicsinc.com (APLM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tharimmune Corporation - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Advanced Biomed Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati genprex.com (GNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati CLDI (Calidi Biotherapeutics)|SBFM (Sunshine Biopharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Xenetic Biosciences, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati SLRX (Salarius Pharma)|Purple Biotech - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AONC (American Oncology Network)|BGNE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Checkpoint Therapeutics Inc. (CKPT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Elevation Oncology, Inc.|ICAD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IKNA|Uzoq muddatli qarzning kapitalga nisbati notablelabs.com (NTBL)|Uzoq muddatli qarzning o'z kapitaliga nisbati Viracta Therapeutics, Inc. VIRX|MOR: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ascentage